{
    "eid": "2-s2.0-84961266765",
    "title": "Statin use is safe and does not impact prognosis in patient with de novo follicular lymphoma treated with immunochemotherapy: An exploratory analysis of the PRIMA cohort study",
    "cover-date": "2016-04-01",
    "subject-areas": [
        {
            "$": "Hematology",
            "@code": "2720"
        }
    ],
    "keywords": [],
    "authors": [
        "Emmanuel Bachy"
    ],
    "citedby-count": 8,
    "ref-count": 30,
    "ref-list": [
        "Watchful waiting in low-tumor burden follicular lymphoma in the rituximab era: Results of an F2-study database",
        "Natural history of and therapy for the indolent non-Hodgkin's lymphomas",
        null,
        "Follicular lymphoma: Prognostic factors for response and survival",
        "Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma",
        "Rituximab added to first-line mitoxantrone, chlorambucil, and prednisolone chemotherapy followed by interferon maintenance prolongs survival in patients with advanced follicular lymphoma: An East German study group hematology and oncology study",
        "Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: Results of a prospective randomized study of the German Low-Grade Lymphoma Study Group",
        "Improvement of overall and failure-free survival in stage IV follicular lymphoma: 25 years of treatment experience at the University of Texas M.D. Anderson Cancer Center",
        "Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: Results of the GELA-GOELAMS FL2000 study",
        "Improved survival of follicular lymphoma patients in the United States",
        "Maintenance rituximab after cyclophosphamide, vincristine, and prednisone prolongs progression-free survival in advanced indolent lymphoma: Results of the randomized phase III ECOG1496 study",
        "Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma",
        "Long-term follow-up of patients with newly diagnosed follicular lymphoma in the prerituximab era: Effect of response quality on survival - A study from the groupe d'etude des lymphomes de l'adulte",
        "PI3K\u03b4 inhibition by idelalisib in patients with relapsed indolent lymphoma",
        "Obinutuzumab (GA101) plus CHOP or FC in relapsed/refractory follicular lymphoma: Results of the GAUDI study (BO21000)",
        "Statin use and reduced cancer-related mortality",
        "Am J Med",
        "Use of statins and the risk of death in patients with prostate cancer",
        "Statins impair antitumor effects of rituximab by inducing conformational changes of CD20",
        "Prenyltransferases regulate CD20 protein levels and influence anti-CD20 monoclonal antibody-mediated activation of complement-dependent cytotoxicity",
        "Statin use and prognosis in patients with diffuse large B-cell lymphoma and follicular lymphoma in the rituximab era",
        "Concomitant statin use does not impair the clinical outcome of patients with diffuse large B cell lymphoma treated with rituximab-CHOP",
        "Statin and aspirin use is associated with improved outcome of FCR therapy in relapsed/refractory chronic lymphocytic leukemia",
        "Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): A phase 3, randomised controlled trial",
        "Revised response criteria for malignant lymphoma",
        "Potential antitumor effects of statins (Review).",
        "HMG-CoA reductase inhibitors induce apoptosis of lymphoma cells by promoting ROS generation and regulating Akt, Erk and p38 signals via suppression of mevalonate pathway",
        "Statins impair glucose uptake in tumor cells",
        "Trends in statin use and low-density lipoprotein cholesterol levels among US adults: Impact of the 2001 National Cholesterol Education Program guidelines",
        "Statin-independent prognosis of patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapy"
    ],
    "affiliation": [
        {
            "affiliation-city": "Palma",
            "affilname": "Hospital Universitari Son Ll\u00e0tzer",
            "affiliation-country": "Spain"
        },
        {
            "affiliation-city": "Melbourne",
            "affilname": "Peter Maccallum Cancer Centre",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Sydney",
            "affilname": "Concord Repatriation General Hospital",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Marseille",
            "affilname": "Institut Paoli-Calmettes",
            "affiliation-country": "France"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Villejuif",
            "affilname": "Institut de Cancerologie Gustave Roussy",
            "affiliation-country": "France"
        },
        {
            "affiliation-city": "Rennes",
            "affilname": "H\u00f4pital Pontchaillou",
            "affiliation-country": "France"
        },
        {
            "affiliation-city": "Lisbon",
            "affilname": "Instituto Portugues de Oncologia de Francisco Gentil Lisboa",
            "affiliation-country": "Portugal"
        },
        {
            "affiliation-city": "Reims",
            "affilname": "CHU de Reims",
            "affiliation-country": "France"
        },
        {
            "affiliation-city": "Hradec Kralove",
            "affilname": "Fakultn\u00ed Nemocnice Hradec Kr\u00e1lov\u00e9",
            "affiliation-country": "Czech Republic"
        },
        {
            "affiliation-city": "Brussels",
            "affilname": "Cliniques Universitaires Saint-Luc",
            "affiliation-country": "Belgium"
        },
        {
            "affiliation-city": "Lyon",
            "affilname": "Centre Hospitalier Lyon-Sud",
            "affiliation-country": "France"
        },
        {
            "affiliation-city": "Lyon",
            "affilname": "Deparment of Biostatistics",
            "affiliation-country": "France"
        },
        {
            "affiliation-city": "La Roche-sur-Yon",
            "affilname": "Centre Hospitalier de la Roche sur Yon",
            "affiliation-country": "France"
        },
        {
            "affiliation-city": "Bordeaux",
            "affilname": "Hematology Department",
            "affiliation-country": "France"
        }
    ],
    "funding": []
}